The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides

Biomaterials

Volumn 32, Issue 18, 2011, Pages 4238-4242

  Yamamoto, Masaki ^a   Sato, Takashi ^a   Beren, Joel ^b   Verthelyi, Daniela ^c   Klinman, Dennis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

CpG oligonucleotide; Primate; TLR9; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEX INTERACTION; CPG OLIGODEOXYNUCLEOTIDES; CPG OLIGONUCLEOTIDE; CPG-ODN; IMMUNE CELLS; INNATE IMMUNE SYSTEMS; KERATINOCYTE MIGRATION; MURINE MODEL; NON-HUMAN PRIMATE; PRIMATE; SKIN BIOPSIES; SKIN INJURIES; TLR9; TOLL-LIKE RECEPTORS; WOUND CLOSURE; WOUND HEALING;

BIOPSY; CELL CULTURE; MAMMALS; OLIGONUCLEOTIDES;

ENDOTHELIAL CELLS;

CPG OLIGODEOXYNUCLEOTIDE; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1ALPHA; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR ALPHA; WOUND HEALING PROMOTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SKIN BIOPSY; SKIN INJURY; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; KERATINOCYTES; MACACA MULATTA; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTORS; WOUND HEALING;

MACACA MULATTA; MURINAE; PRIMATES;

EID: 79955079914     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.043     Document Type: Article

References (44)

1. Madison K.C. Barrier function of the skin: " la raison d'etre" of the epidermis. J Invest Dermatol 2003, 121:231-241.
2. Singer A.J., Clark R.A. Cutaneous wound healing. N Engl J Med 1999, 341:738-746.
3. Tsirogianni A.K., Moutsopoulos N.M., Moutsopoulos H.M. Wound healing: immunological aspects. Injury 2006, 37:S5-S12.
4. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
5. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
6. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004, 56:549-580.
7. Frantz S., Vincent K.A., Feron O., Kelly R.A. Innate immunity and angiogenesis. Circ Res 2005, 96:15-26.
8. Broadley K.N., Aquino A.M., Woodward S.C., Buckley-Sturrock A., Sato Y., Rifkin D.B., et al. Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest 1989, 61:571-575.
9. Koff J.L., Shao M.X., Kim S., Ueki I.F., Nadel J.A. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J Immunol 2006, 177:8693-8700.
10. Straino S., Di C.A., Mangoni A., De M.R., Guerra L., Maurelli R., et al. High-mobility group box 1 p.otein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008, 128:1545-1553.
11. Macedo L., Pinhal-Enfield G., Alshits V., Elson G., Cronstein B.N., Leibovich S.J. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 2007, 171:1774-1788.
12. Razin A., Friedman J. DNA methylation and its possible biological roles. Prog Nucleic Acid Res Mol Biol 1981, 25:33-52.
13. Cardon L.R., Burge C., Clayton D.A., Karlin S. Pervasive CpG suppression in animal mitochondrial genomes. Proc Natl Acad Sci U S A 1994, 91:3799-3803.
14. Krieg A.M., Yi A., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-548.
15. Klinman D.M., Yi A., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNg. Proc Natl Acad Sci U S A 1996, 93:2879-2883.
16. Wagner H. Bacterial CpG-DNA activates immune cells to signal " infectious danger" Adv Immunol 1999, 73:329-368.
17. Hemmi H., Takeuchi O., Kawai T., Sato S., Sanjo H., Matsumoto M., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
18. Takeshita F., Leifer C.A., Gursel I., Ishii K., Takeshita S., Gursel M., et al. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001, 167:3555-3558.
19. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004, 4:249-258.
20. Sato T., Yamamoto M., Shimosato T., Klinman D.M. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen 2010, 18:586-593.
21. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001, 98:9237-9242.
22. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 2001, 11:333-340.
23. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 2001, 166:2372-2377.
24. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., et al. Identification of CpG oligonucleotide sequences with high induction of IFNa/b in plasmacytoid dendritic cells. Eur J Immunol 2001, 31:2154-2163.
25. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol 2003, 33:1633-1641.
26. Verthelyi D., Kenney R.T., Seder R.A., Gam A.A., Friedag B., Klinman D.M. CpG oligodeoxynucleotides as vaccine adjuvants in primates. J Immunol 2002, 168:1659-1663.
27. Verthelyi D., Klinman D.M. Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates. Clin Immunol 2003, 109:64-71.
28. Devalaraja R.M., Nanney L.B., Du J., Qian Q., Yu Y., Devalaraja M.N., et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000, 115:234-244.
29. Ishida Y., Gao J.L., Murphy P.M. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008, 180:569-579.
30. White S.R., Tse R., Marroquin B.A. Stress-activated protein kinases mediate cell migration in human airway epithelial cells. Am J Respir Cell Mol Biol 2005, 32:301-310.
31. Bove P.F., Wesley U.V., Greul A.K., Hristova M., Dostmann W.R., van d V. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol 2007, 36:138-146.
32. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997, 276:75-81.
33. Miller L.S. Toll-like receptors in skin. Adv Dermatol 2008, 24:71-87.
34. James L.C., Moore A.M., Wheeler L.A., Murphy G.M., Dowd P.M., Greaves M.W. Transforming growth factor alpha: in vivo release by normal human skin following UV irradiation and abrasion. Skin Pharmacol 1991, 4:61-64.
35. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000, 7:165-197.
36. Clark R.A.F. The molecular and cellular biology of wound repair 1996, Plenum Press, New York. 2nd ed.
37. Werner S., Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 2001, 11:143-146.
38. Sato N., Fujii A. Effects of interleukin-1alpha on the production and release of basic fibroblast growth factor in cultured nifedipine-reactive gingival fibroblasts. J Oral Sci 2008, 50:83-90.
39. Lee P., Lee D.J., Chan C., Chen S.W., Ch'en I., Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 2009, 458:519-523.
40. Miller L.S., Sorensen O.E., Liu P.T., Jalian H.R., Eshtiaghpour D., Behmanesh B.E., et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005, 174:6137-6143.
41. Horner A.A., Raz E. Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J Allergy Clin Immunol 2002, 110:706-712.
42. Halperin S.A., Van Nest G., Smith B., Abtahi S., Whiley H., Eiden J.J. A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine 2003, 21:2461-2467.
43. Klinman D.M., Ishii K.J., Gursel M., Gursel I., Takeshita S., Takeshita F. Immunotherapeutic applications of CpG-containing oligodeoxynucleotides. Drug News Perspect 2000, 13:289-296.
44. Klinman D.M. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2003, 2:305-315.